Add BrightSurf on Google Email

Science News for November 5, 2004


NIH recognizes IU as leader in STD research

The NIH awarded Indiana University a $7 million grant to establish the Midwest Sexually Transmitted Infections and Topical Microbicides Cooperative Research Center. The center will focus on researching epidemiology, acquisition, prevention, and pathogenesis of sexually transmitted infections in young women.

Tuberculosis drug combined with virtual reality therapy is effective in treating fear of heights

A study of 28 individuals with acrophobia found that combining D-cycloserine (DCS) with virtual reality exposure therapy significantly reduced fear of heights, with effects lasting at least three months. The treatment works by facilitating 'fear extinction' in the brain, a process previously used to treat phobias and post-traumatic str...

SourceEmory University Health Sciences Center·JournalArchives of General Psychiatry·DateNov 5, 2004

Occult hepatitis B in dialysis patients

A recent study published in Hepatology found that occult HBV infection is prevalent in adult hemodialysis patients, with a rate four to five times higher than standard HBsAg testing. The majority of infections were associated with low viral loads and the sG145R-mutant.

SourceWiley·JournalHepatology·DateNov 5, 2004